This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The $2,012,758.65 single-award contract, which has a period of performance ending on September 30, 2026, is for the provision of compounded chemotherapy and other specialized pharmaceutical services primarily to support the VA's Veterans Health Administration. The contract originated from an unrestricted/full and open...
This federal contract IDV award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 and Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The single-award BPA, valued at up to $1,415,000, provides chemo compounding services to support the VA's oncology and infusion treatment programs when the agency's on-site compounding capabilities are temporarily unavailable. The contract tasks Optum...
The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition. Under this IDC, the VA-VHA has...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) and Veterans Health Administration (VHA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract has a ceiling value of $416,900.00 and a period of performance through November 19, 2025. Optum Pharmacy 601 is providing chemotherapy compound drug hood services to support veterans' healthcare programs, particularly through the VA's Veterans Integrated Service Networks...
The Department of Veterans Affairs (VA) has awarded a single-award Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for pharmacy compounding services. The $800,000 IDC has a performance period through November 2029 and allows the VA to issue task orders for specialized pharmaceutical products and services as needed. Under this IDC, Optum Pharmacy 801, Inc. provides customized chemotherapy agents, hazardous sterile preparations,...
This single-award Indefinite Delivery Contract (IDC) was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 20 (VISN 20) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The $2,500,000 contract provides pharmacy compounding services, with a focus on chemotherapy, hazardous sterile preparations, and specialized pharmaceutical solutions, primarily to support the VA healthcare system. The contract...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide nationwide pharmacy compounding services. The contract has a ceiling value of $10,000,000 and a period of performance through October 31, 2025. Under this IDC, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) will provide highly specialized pharmaceutical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a single award, indefinite delivery contract valued at up to $4,050,000 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. Two firm fixed price delivery orders have been issued against the contract to date for 503A Pharmaceutical Drug Compounding Services. The first delivery order, issued on August 25, 2023, is...
The federal contract IDV award is for Chemo Compounding Services provided by Optum Pharmacy 801, Inc. (dba Avella Specialty Pharmacy), a subsidiary of UnitedHealth Group Incorporated. As the prime contractor, Avella will be responsible for compounding customized chemotherapy agents, hazardous sterile preparations, intravenous solutions, and other medications based on patient-specific orders to support the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) healthcare...
The federal contract IDV awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, is for the provision of specialized pharmacy compounding services to support the Veterans Integrated Service Network 16 (VISN 16) in the Gulf Coast region. Under this single-award $4.5M Indefinite Delivery Contract, which has a period of performance through September 2024, Optum Pharmacy 601 will deliver a range of customized pharmaceutical...